688505 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Watchlist

8.43
-0.22-2.54%

Market Closed Dec 13 15:00 CST

8.74BMarket Cap83.47P/E (TTM)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Key Stats

According to the latest financial report of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd., the latest earnings per share (TTM) for the company is 0.08. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s latest financial report to see how much their book value per share (BVPS) is currently at 2.27.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. shows that the company's current ratio is 6.23, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd., the quick ratio is 6.06, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

ROE

Want to learn more about the financial health of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.? The latest ROE figure is 3.67%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd., the total asset return on investment (ROA) is 3.13%.

Currency: CNY

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s latest financial report to see how their gross margin is doing - currently at 91.79%.

Currency: CNY

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd., the net profit margin is 15.70%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Zhejiang Zoenn Design

300901

14.86 +20.03%

Zhejiang Meorient Commerce & Exhibition Inc.

300795

22.36 +20.02%

Fujian Zitian Media Technology